» Articles » PMID: 30367038

Deacetylation of Serine Hydroxymethyl-transferase 2 by SIRT3 Promotes Colorectal Carcinogenesis

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Oct 28
PMID 30367038
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

The conversion of serine and glycine that is accomplished by serine hydroxymethyltransferase 2 (SHMT2) in mitochondria is significantly upregulated in various cancers to support cancer cell proliferation. In this study, we observed that SHMT2 is acetylated at K95 in colorectal cancer (CRC) cells. SIRT3, the major deacetylase in mitochondria, is responsible for SHMT2 deacetylation. SHMT2-K95-Ac disrupts its functional tetramer structure and inhibits its enzymatic activity. SHMT2-K95-Ac also promotes its degradation via the K63-ubiquitin-lysosome pathway in a glucose-dependent manner. TRIM21 acts as an E3 ubiquitin ligase for SHMT2. SHMT2-K95-Ac decreases CRC cell proliferation and tumor growth in vivo through attenuation of serine consumption and reduction in NADPH levels. Finally, SHMT2-K95-Ac is significantly decreased in human CRC samples and is inversely associated with increased SIRT3 expression, which is correlated with poorer postoperative overall survival. Our study reveals the unknown mechanism of SHMT2 regulation by acetylation which is involved in colorectal carcinogenesis.

Citing Articles

The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.


Mild neurodevelopmental disorder due to reduced SHMT2 enzymatic activity caused by novel compound heterozygous variants: expanding the phenotypic spectrum.

Pan H, He M, Luo X, Hu J, Mao X, Cheng Y Neurogenetics. 2024; 26(1):7.

PMID: 39589606 DOI: 10.1007/s10048-024-00784-6.


Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.

Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z Theranostics. 2024; 14(17):6726-6767.

PMID: 39479446 PMC: 11519805. DOI: 10.7150/thno.100667.


Loss of USP10 promotes hepatocellular carcinoma proliferation by regulating the serine synthesis pathway through inhibition of LKB1 activity.

Ma C, Lin Z, Yao J, Qin W, Wang X, Li Q Cancer Sci. 2024; 115(12):3902-3914.

PMID: 39327097 PMC: 11611778. DOI: 10.1111/cas.16336.


Classical swine fever virus inhibits serine metabolism-mediated antiviral immunity by deacetylating modified PHGDH.

Li X, Huang Y, Liu X, Zhang L, Wang X, Zhao F mBio. 2024; 15(10):e0209724.

PMID: 39207107 PMC: 11481501. DOI: 10.1128/mbio.02097-24.


References
1.
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-42. DOI: 10.1056/NEJMoa032691. View

2.
Giardina G, Brunotti P, Fiascarelli A, Cicalini A, Costa M, Buckle A . How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state. FEBS J. 2015; 282(7):1225-41. DOI: 10.1111/febs.13211. View

3.
Schwer B, North B, Frye R, Ott M, Verdin E . The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol. 2002; 158(4):647-57. PMC: 2174009. DOI: 10.1083/jcb.200205057. View

4.
Wang Y, Wang H, Xu J, Tan J, Fu L, Wang J . Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner. Nat Commun. 2018; 9(1):545. PMC: 5803207. DOI: 10.1038/s41467-018-02951-4. View

5.
Hershko A, Ciechanover A . The ubiquitin system. Annu Rev Biochem. 1998; 67:425-79. DOI: 10.1146/annurev.biochem.67.1.425. View